FDA Investigator Craig A Garmendia

Craig A Garmendia has conducted inspections on 217 sites in 27 countries as of 29 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
217
Last Inspection Date:
29 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100005632
Countries of Inspections:
United States of America, India, France, Australia, New Zealand, Canada, Belize, Thailand, Moldova (Republic of), Germany, Spain, Austria, Poland, Hungary, United Kingdom of Great Britain and Northern Ireland, Korea (Republic of), Japan, South Africa, Italy, Switzerland, Argentina, Czechia, Ukraine, Georgia, Denmark, Puerto Rico, Taiwan
FDA Investigators that have inspected at least one site in common with Craig A Garmendia:
Aaron F Coleman, Adam M Derr, Ademola O Daramola, Alanna L Mussawwir Bias, Albert A Salvador, Allen F Hall, Amanda E Lewin, PhD, Ana Delp Cintron, Ana P Barido, Andrea A Branche, Anita Narula, PhD, Annette Melendez, Anthony J Grace, Arindam Dasgupta, PhD, Arsen Karapetyan, Barbara A Rusin, Barbara D Wright, Barbara M Frazier, Benita C Okeke, Betsy C Galliher, Bill Tacket, Jr, Bonita S Chester, Brooke K Higgins, Brunilda Torres, Byungja E Marciante, Cara L Alfaro, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Cheryl A Grandinetti, Chiaochun J Wang, Chikako Torigoe, PhD, Christian D Lynch (CDL), Christos G Tsingelis, Clara E Santiago, Clotia Cabbey Mensah, Colleen M Aspinwall, Courtney A Gilbert, Courtney A Hunt, Courtney N Long, Craig T Rybus, Dandan Wang, PhD, Daniel J Roberts, Daniel L Aisen, David R Heiar, Dawn C Olenjack, Dawn M Mccabe, Dawne M Hines, Dennis R Hock, Devaughn Edwards, Dianiris C Ayala, Dianne H Milazzo, Don A Leeseberg, Dr. Gopa Biswas, PhD, Dr. Sriram Subramaniam, PhD, Dyvette Arline, Eduardo Carbonell, Edwin J Gorney, Emily A Baldwin, Emir Galevi, Ethan P Stegman, Fabian Nchaparro Rodriguez, Farhana Khan, Figarole, Gabriel E Muniz, Gajendiran Mahadevan, PhD, Gene R Gunn, George C Amedro, George Pyramides, Gerald N Mcgirl, DDS, German Rivera, Gisselle I Sensebe, Gloria E Parra, Gulshan R Anand, Habacuc V Barrera, Hasan A Irier, PhD, Heather M Bullock, Hector Jcolon Torres, Himanshu Gupta, PhD, Holly Brevig, Jacqueline Mdiaz Albertini, James E Frye, James L Dunnie, Jr, James M Kewley, James P Mcevoy, James To Neal, Jana L Caylor, Janete F Guardia, Jean M Mulinde, MD, Jeanne J Thai, Jennifer Adams, MPH, Jennifer C Adams, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer L Sheehan, Jennifer Lalama, Jennifer M Menendez, Jessica L Pressley, Joann Walters Salvatierra, Joanne E King, Jogy George, John A Kadavil, PhD, Jonee J Mearns, Jose Acruz Gonzalez, Ka L Wong, Kara A Scheibner, PhD, Karen M Cooper, Karen M Rodriguez, Karl D Hezel, Katherine M Taylor, Kathleen V Ferguson, Kathryn A Krentz, Kelly M Byers, Ladislav Kermet, Lakecha N Lewis, Larry K Austin, Laura E Garcia, Lawrence Y Lee, PhD, LCDR Angelica M Chica, LCDR Randall L Morris, Leo J Lagrotte, Leslie A Jackanicz, Li Hongpaul Yeh, PhD, Libia M Lugo, Liming Zhang, Linda K Matheny, Linda R Kuchenthal, Lisa P Oakes, Lori A Gioia, Lt Bill Tackett, Jr, LT Richard A Lyght, Luz I Collado, Makini Cobourne Duval, PhD, Marc Balzarini, Margaret Torres Vazquez, Maria V Price, Mark V Preciados, Martin K Yau, PhD, Matthew C Watson, Matthew F Duff, Matthew T Sanchez, Melissa D Ray, Melkamu Getie Kebtie, PhD, Mendoza, Michael A Charles, Michael C Lombardi, Michael E Maselli, Michael P Anthony, Michael Serrano, Michelle D Haamid, Michelle M Noe Varga, Michelle Yclark Stuart, Miguel A Martinez Perez, Minh D Phan, Mizanne E Lewis, Mohsen Rajabi Abhari, FDA, Mra Mcculloughj, Nancy A Bellamy, Nicola M Fenty Stewart, Nicolas Riveratorres, Nicole E Knowlton, Nicole M Bell, Niketa Patel, Nilufer M Tampal, PhD, Omayra Nrodriguez Ruiz, Ormond, Parul M Patel, Patricia F Hughes, PhD, Patrick L Wisor, Paul L Figarole, Jr, Paula M Laplant, Perry H Gambrell, Prabhu P Raju, Rachel A Peters, Rachel C Dailey, Ramon H Pabon Aponte, Randy L Clarida, Raymond A Lyn, Jr, Rebecca E Dombrowski, Rebecca Rodriguez, Rebecca T Davis, Reyes Candau Chacon, PhD, Richard K Vogel, Richard W Berning, Rina Bhikha, Robert D Tollefsen, Ronald Ifraimov, Roy R Rinc, Ruben C Ayala, PharmD, Ruth A Williams, Samantha J Pinizzotto, D V M, Samina S Khan, Sandra S Saniga, Sarah E Mcmullen, Saundrea A Munroe, Scott B Laufenberg, Seongeun Cho (Julia), PhD, Sereen Gmorgan Murray, Sharon Giamberini, Sharon L Matson, Sherbet L Samuels, Sheri L Stephenson, Sidney B Priesmeyer, Sonia M Monges, Sripal R Mada, PhD, Stacey L Witherwax, Stanley B Eugene, BS, BME, Stephanie D Crockett, Stuart W Russell, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan M Corrales, Susan M Turcovski, Suzanne N Vallez, Tawny L Colling, Teresa I Navas, Thea C Grome, Thomas J Arista, Thomas W Nojek, Thuy T Nguyen, LCDR, Timothy C Grome, Tina A Desorcy, Tina M Pawlowski, Torrance J Slayton, Tracey L Harris, Traci M Armand, Vanessa E Coulter, Victor Spanioli, Virginia L Meeks, Viviana Matta, Walden H Lee, Wayne E Seifert, William P Tonkins, Xianghong Jing (Emily), PhD, Xikui Chen (nmi), PhD, Yiyue Zhang (nmi), PhD, Young M Choi, PhD, Yumi J Hiramine, Zerita White

Craig A Garmendia's Documents

Publish Date Document Type Title
October, 2018 FDA 483 Raimundo J. Acosta, MD - Form 483, 2018-10-02
December, 2011 FDA 483 Phase One Solutions, Inc. - Form 483, 2011-12-01
March, 2013 EIR Research Triangle Institute - EIR, 2013-03-06
October, 2014 FDA 483 Response Marquez, Farid - Form 483R, 2014-10-23
June, 2019 EIR ICS Arensia Exploratory Medicine SRL - EIR, 2019-06-20
October, 2014 FDA 483 Marquez, Farid - Form 483, 2014-10-06
May, 2015 FDA 483 Mark E. Kutner, MD - Form 483, 2015-05-15
March, 2013 EIR WIL Research - EIR, 2013-03-07
May, 2016 FDA 483 Martin Valdes, M.D. - Form 483, 2016-05-05
April, 2013 EIR David H. Flaherty - EIR, 2013-04-01
March, 2012 FDA 483 Zachary K. Segal, M.D. - Form 483, 2012-03-02
April, 2017 FDA 483 Yvelice Villaman-Bencosme - Form 483, 2017-05-02
March, 2013 FDA 483 WIL Research - Form 483, 2013-03-07
January, 2018 FDA 483 Shevanti M. Jegasothy, MD - Form 483, 2018-01-19
April, 2023 FDA 483 Jacek Mackiewicz, MD, PhD - Form 483, 2023-04-28
August, 2018 FDA 483 Celestino P. Castellon, MD - Form 483, 2018-08-30
May, 2013 EIR Ana J. Fandino - EIR, 2013-05-22
May, 2013 FDA 483 Response Ana J. Fandino - Form 483R, 2013-06-03
September, 2010 EIR Lex Inc - EIR, 2010-09-28
May, 2021 FDA 483 Joseph A. Zadra, MD - Form 483, 2021-05-07
April, 2015 FDA 483 Gilbert R. Weiner, DO - Form 483, 2015-04-30
August, 2021 EIR Marc C. Gittelman, M.D. - EIR, 2021-08-26
May, 2013 FDA 483 Ana J. Fandino - Form 483, 2013-05-22
September, 2009 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2009-09-04
May, 2015 EIR Mark E. Kutner, MD - EIR, 2015-05-15
August, 2021 FDA 483 Marc C. Gittelman, M.D. - Form 483, 2021-08-26
November, 2013 FDA 483 Response Weiner, Gilbert R. - Form 483R, 2013-12-03
April, 2013 FDA 483 David H. Flaherty - Form 483, 2013-03-20
April, 2015 EIR Gilbert R. Weiner, DO - EIR, 2015-04-30
November, 2013 FDA 483 Weiner, Gilbert R. - Form 483, 2013-11-25
May, 2015 FDA 483 Mark E. Kutner, M.D. - Form 483, 2015-05-15
August, 2022 FDA 483 Thatthan Suksombooncharoen, MD - Form 483, 2022-08-26
November, 2013 EIR Weiner, Gilbert R. - EIR, 2013-11-25
August, 2017 FDA 483 Hector S. Rodriguez, MD - Form 483, 2017-08-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more